癌症和传统合成DMARDS的风险:一个叙述性回顾
Thelma Skare1, Jozélio Freire de Carvalho2
1Department of Rheumatology, Hospital Evangélico Mackenzie, Curitiba, PR, Brazil.
Northern clinics of Istanbul
|August 22, 2025
概括
传统的修改疾病的抗风湿药物 (DMARDs) 治疗风湿性疾病,但可能会增加癌症风险. 本审查审查了这些广泛使用的免疫抑制剂和免疫调节剂的潜在致癌性.
科学领域:
- 关节病学
- 癌症学
- 药理学
背景情况:
- 免疫抑制剂和免疫调节剂对于治疗风湿性疾病至关重要.
- 常规疾病修饰性抗风湿药物 (DMARDs) 包括美托雷克萨特,阿扎西奥普林,抗疟疾药物和环素.
- 这些疗法旨在诱导缓解和控制炎症,改善患者的预后.
研究的目的:
- 审查关于常规疾病修饰性抗瘤药物 (DMARD) 致癌潜力的现有文献.
- 评估使用传统的DMARD与患恶性瘤的风险之间的关联.
- 为临床医生和研究人员提供关于DMARD和癌症风险的全面概述.
主要方法:
- 采用了一个叙述性审查方法.
- 对研究DMARD和癌症的数据库进行了文献搜索.
- 综合了针对常规DMARD和恶性瘤风险的相关研究.
主要成果:
- 传统的DMARD与某些癌症的潜在风险增加有关.
- 特定的DMARD可能具有不同程度的致癌风险.
- 需要进一步的研究来充分阐明DMARD与恶性瘤之间的复杂关系.
结论:
- 虽然在治疗类风湿性疾病方面有效,但传统的DMARDs的致癌潜力需要仔细考虑.
- 在处方这些药物时,风险益处评估至关重要.
- 持续监测和研究对于减轻潜在的不良影响和优化患者护理至关重要.
相关概念视频
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Hazard Ratio
243
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
243
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231
Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62


